![George Ng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
George Ng
Directeur Général chez
PROCESSA PHARMACEUTICALS, INC.
Fortune : 45 967 $ au 31/07/2026
Profil
George K.
Ng was the founder of Scilex Pharmaceuticals, Inc., founded in 2012, serving as President from 2012 to 2019.
Mr. Ng is the founder of IACTA Pharmaceuticals, Inc., founded in 2016, holding the title of Director & Chief Business Officer since 2020.
Mr. Ng is the founder of Peng Life Science Ventures, founded in 2013, serving as Partner since 2013.
Mr. Ng is currently Chief Executive Officer & Director at Processa Pharmaceuticals, Inc. since 2023.
Mr. Ng is currently Director at TuHURA Biosciences, Inc. (Old) since 2020.
Mr. Ng is currently Independent Director at TuHURA Biosciences, Inc. since 2024.
Former positions include Director at Inflammatory Response Research, Inc. from 2019 to 2020; Director at Virttu Biologics Ltd. from 2017 to 2019; Director at Immuneoncia Therapeutics, Inc. from 2016 to 2019; Director at Invent Medical Corp.
from 2019 to 2020; President, Chief Operating Officer & Director at Calidi Biotherapeutics (Nevada), Inc. from 2022 to 2023; Director at Calidi Biotherapeutics, Inc. from 2023 to 2024; Chief Compliance Officer & Head-Legal at Spectrum Pharmaceuticals, Inc. from 2007 to 2010; Senior Vice President & General Counsel at BioDelivery Sciences International, Inc. from 2012 to 2015; Secretary, Chief Legal Officer & Executive VP at Sorrento Therapeutics, Inc. in 2015; President at Pan Asian Lawyers of San Diego; Chief Legal Officer at Alpharma, Inc. Education includes undergraduate studies at the University of California, Davis and graduate studies at the University of Notre Dame The Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/08/2026 | 21 380 ( 0,77 % ) | 45 967 $ | 31/07/2026 | |
-.--% | 26/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de George Ng
| Sociétés | Poste | Début |
|---|---|---|
| PROCESSA PHARMACEUTICALS, INC. | Directeur Général | 08/08/2023 |
Peng Life Science Ventures | Fondateur | 01/09/2013 |
TuHURA Biosciences, Inc. (Old)
 TuHURA Biosciences, Inc. (Old) BiotechnologyHealth Technology Develops cancer vaccines and tumor microenvironment modulators | Directeur/Membre du Conseil | 01/02/2020 |
IACTA Pharmaceuticals, Inc.
 IACTA Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and commercializes eyecare products | Fondateur | 01/01/2016 |
Anciens postes connus de George Ng
| Sociétés | Poste | Fin |
|---|---|---|
| CALIDI BIOTHERAPEUTICS, INC. | President | 23/06/2023 |
Calidi Biotherapeutics, Inc. (United States)
 Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage immuno-oncology company | President | 23/06/2023 |
Inflammatory Response Research, Inc.
 Inflammatory Response Research, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of inflammatory disorders and conditions | Directeur/Membre du Conseil | 01/04/2020 |
Invent Medical Corp.
 Invent Medical Corp. Medical SpecialtiesHealth Technology Develops respiratory care devices | Directeur/Membre du Conseil | 01/01/2020 |
Scilex Pharmaceuticals, Inc.
 Scilex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes non-opioid pain management products | Fondateur | 01/04/2019 |
Formation de George Ng
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
59
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Spectrum Pharmaceuticals, Inc.
 Spectrum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel and targeted oncology & hematology drug products | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
TuHURA Biosciences, Inc. (Old)
TuHURA Biosciences, Inc. (Old) BiotechnologyHealth Technology Develops cancer vaccines and tumor microenvironment modulators | Health Technology |
Inflammatory Response Research, Inc.
Inflammatory Response Research, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of inflammatory disorders and conditions | Health Technology |
Scilex Pharmaceuticals, Inc.
Scilex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes non-opioid pain management products | Health Technology |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sorrento Therapeutics, Inc.
 Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
University of Notre Dame The Law School
 University of Notre Dame The Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Virttu Biologics Ltd.
 Virttu Biologics Ltd. Pharmaceuticals: OtherHealth Technology Develops oncolytic virus therapy for treatment of cancer | Health Technology |
Pan Asian Lawyers of San Diego | |
IACTA Pharmaceuticals, Inc.
IACTA Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and commercializes eyecare products | Health Technology |
Processa Pharmaceuticals, Inc.
 Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
Immuneoncia Therapeutics, Inc.
 Immuneoncia Therapeutics, Inc. BiotechnologyHealth Technology Provides drug development and antibody engineering services for oncology patients | Health Technology |
Calidi Biotherapeutics, Inc. (United States)
Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage immuno-oncology company | Commercial Services |
Peng Life Science Ventures | |
Invent Medical Corp.
Invent Medical Corp. Medical SpecialtiesHealth Technology Develops respiratory care devices | Health Technology |
Calidi Biotherapeutics, Inc.
 Calidi Biotherapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies which attacks solid tumors | Health Technology |
